Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients by Takada H, Nishikomori R, Imagawa T, Lheritier K, Preiss R, Patel N, Gattorno M, Kuemmerle-Deschner J, Hachulla P, Bader-Meunier B, Heike T, Hara T, Yokota S

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a... by McCann L, Ozdogan H, Rutkowska-Sak L, Ferrandiz MA, Wulffraat NM, Brik R, Kallinich T, Erguven M, Berkun Y, Constantin T, Quartier P, Horneff G, Brunner H, Ruperto N, Lheritier K, Preiss R, Tseng L, Martini A, Lovell DJ

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis by Mallon, A-M, Häring, DA, Dahlke, F, Aarden, P, Afyouni, S, Delbarre, D, El Emam, K, Ganjgahi, H, Gardiner, S, Kwok, CH, West, DM, Straiton, E, Haemmerle, S, Huffman, A, Hofmann, T, Kelly, LJ, Krusche, P, Laramee, M-C, Lheritier, K, Ligozio, G, Readie, A, Santos, L, Nichols, TE, Branson, J, Holmes, C